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PROMINENT FEATURES OF ALLERGIC ANGIOEDEMA ON 
ORAL MUCOSA
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SUMMARY – Angioedema indicates acute subcutaneous edema that characterizes improperly 
restricted cutaneous or mucous membrane swelling, which can occur only once or be relapsing. 
Edema usually occurs in the periorbital area, lips, tongue, extremities and intestinal wall. It has 
turned out that angioedema is usually caused by the use of angiotensin-converting enzyme inhibi-
tors (ACE) or allergies to certain allergens (allergic or IgE-mediated angioedema), followed by C1 
inhibitor deficiency (hereditary and acquired angioedema), or the cause is unknown (idiopathic an-
gioedema). It has been shown that patients with angioedema often have urticaria, which is noted in 
approximately 50% of cases. Usually there is a type I allergic reaction to some food allergens or drugs 
or insect stings. The most common causes of allergic angioedema are bee and wasp stings, reactions 
to medications or injections for sensitivity testing, and certain foods (especially eggs, shellfish and 
nuts). In diagnostic terms, it is important to determine the potential allergen, which is commonly 
performed with cutaneous tests, such as prick test, etc. The main risk of angioedema is swelling of 
the tongue, larynx and trachea, which can lead to airway obstruction and death, therefore trache-
otomy is indicated in such cases. The initial treatment of patients with most forms of angioedema 
included administration of antihistamines and glucocorticoids, while epinephrine is given if there is 
fear from laryngeal edema.
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Introduction
Angioedema is a term describing acute edema of 
the skin or mucosa, characterized by an irregularly 
shaped swelling, which usually manifests itself epi-
sodically1. It affects approximately 15% of the gen-
eral population and is more common in women than 
men2. There are several different angioedema syn-
dromes, but they all have in common a characteristic 
edema caused by the release of vasoactive mediators 
and transient permeability of subcutaneous and sub-
mucous postcapillary venules1. In patients who have 
angioedema the observed edema is usually asymmet-
ric and can cause discomfort as the patient’s subjective 
symptom1. As noticed, patients who have angioedema 
frequently also have urticaria (about 50% of patients)3. 
Common sites of the edema are the periorbital region, 
lips (Fig. 1), tongue, extremities, upper respiratory 
Fig. 1. Angioedema of the upper lip33. 
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pathways and intestinal wall. Angioedema of the in-
testinal wall may also occur without changes of the 
skin and may cause abdominal pain, nausea and less 
often obstruction of bowel lumina. Angioedema may 
also be accompanied by laryngeal edema, with a mor-
tality rate of 25%-40%4. Episodes of swelling usually 
last for two to three days and are either isolated or 
recurrent1. 
The Etiology of Angioedema
Angioedema is usually classified as type I allergic 
reaction (allergic or IgE mediated angioedema). In 
this group of angioedema, a certain allergen is trig-
gering the hypersensitivity reaction by binding to 
IgE, which in turn is causing the release of histamine 
and other vasoactive substances in mast cells5. Symp-
toms usually start to develop in a minute to an hour 
after exposure to the allergen. Most cases of allergic 
angioedema are due to bee and wasp stings, drugs, 
food, especially eggs, mussel and nuts, injections used 
for allergic hypersensitivity testing, etc.
Otherwise, for hereditary and acquired angioede-
ma, as well as for the one associated with medications, 
the key pathogenetic factor is an elevated level of plas-
ma bradykinin. Nevertheless, in angioedema as well as 
in urticaria, the cause often remains unknown6. In case 
of solitary angioedema (without urticaria), the patient 
should be evaluated for drug intake and family medical 
history to identify angioedema associated with angio-
tensin-converting enzyme (ACE) inhibitors or heredi-
tary angioedema7. Among medications, nonsteroidal 
anti-inflammatory drugs (NSAID), antibiotics and an-
tiepileptics most frequently induce angioedema8,9. 
Moreover, acquired forms of angioedema with C1 
inhibitor (C1 INH) deficiency may originate as a re-
sult of autoantibodies binding to it or because of their 
wasting due to activation by paraproteins10. The usual 
findings are decreased levels of complement compo-
nent C4, sometimes also decreased levels of C1 INH, 
as well as the presence of paraproteins7.
Angioedema Due to Angiotensin-Converting Enzyme 
Inhibitors
Angioedema occurs in 0.1%-2.2% of patients tak-
ing ACE inhibitors and probably develops because 
of elevated levels of bradykinin1,11. Manifestation is 
highest during the first month of drug intake (25%), 
although it can manifest itself even after a few years 
of drug usage11. Commonly, it affects the tongue, lips 
and face as edema, also affected may be the phar-
ynx, larynx and internal organs. Fatal outcomes have 
also been recorded, therefore it is obligatory for these 
patients to advise them withdrawal of ACE inhibi-
tors and administration of alternative antihyperten-
sives12-16. Administering C1 inhibitors to such pa-
tients is of no value. Fresh plasma, however, is useful 
at times7,17,18. Antihistamines, corticosteroids and 
adrenaline are often used for therapeutic purpose in 
such individuals, despite their unclear effectiveness. 
Studies have shown an 85% reduction or complete 
remission rate of ACE inhibitor induced angioedema 
after discontinuation of medication7. The individuals 
whose condition is not improving even months after 
stopping their medication, most probably suffer from 
idiopathic angioedema, or they may, nonetheless, have 
occasionally taken an ACE inhibitor.
Angioedema due to C1 Inhibitor Deficiency
Hereditary angioedema or hereditary angioneural 
angioedema is a familial variant of angioedema with a 
C1 INH defect that often involves the intestines6,8. C1 
INH is an alpha-globulin that controls the comple-
ment cascade and its deficiency leads to uncontrolled 
activity of the vasoactive mediators bradykinin, kal-
likrein and plasmin.
This is a rare disorder accounting for approximate-
ly 1% of all angioedema cases. Symptoms usually de-
velop in childhood and adolescence. Women become 
ill more often than men6.
The main disorder in hereditary angioedema is a 
defect in C1 INH, which is inherited as an autosomal-
ly dominant trait, with clinical disorders arising when 
the levels of C1 INH drop below 50%. The majority 
of these patients have decreased enzyme levels. The 
swelling usually lasts for 1-2 hours, resolving sponta-
neously afterwards. They are mostly recurrent6,19.
Also possible is an acquired angioedema with de-
creased levels of C1 INH. This occurs in adulthood 
and has no positive family history. Another possibil-
ity is Caldwell syndrome and the primarily acquired 
angioedema6,20. Caldwell syndrome is an acquired 
angioedema combined with hematologic disorders. 
This is most likely a monoclonal proliferation of B 
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lymphocytes, as in B-lymphocyte lymphoma, chronic 
lymphocytic leukemia or multiple myeloma. In the 
primarily acquired angioedema (acquired angioedema 
type 2), the patient produces IgG and IgM antibodies 
against C1 INH. They block the C1 to C1 INH bind-
ing, which in turn leads to elevated levels of C1, caus-
ing further a vicious cycle by inactivating the enzyme. 
It occurs most often after the fourth decade of life1.
Other Forms of Angioedema 
Sometimes the etiological factor in angioedema 
patients cannot be determined, which points to idio-
pathic angioedema. According to some studies, this 
type of angioedema occurs most frequently in the 
group of angioedemas (Table 1, Fig. 2), comprising 
around 38% of cases1,21.
Angioedema also arises from physical stimulation 
such as cold, heat, vibration, trauma, emotional stress 
and ultraviolet radiation6,1. There is also a cytokine-as-
sociated angioedema, known as episodic angioedema 
with eosinophilia (Gleich syndrome), which is char-
acterized by fever, elevated blood levels of eosinophils 
and IgM. Its true cause is unknown. Elevated levels 
of cytokines, granulocytes, macrophages, interleukins 
(IL-3, IL-5 and IL-6) as well as CD4+ lymphocytes 
are verified, which engage in the pathogenesis of the 
whole process1. 
The Pathogenesis of Allergic Reactions in Angioedema
Hypersensitivity reactions can be mediated 
through antibodies (reactions of immediate hypersen-
sitivity, type I-III) or through cells (delayed hypersen-
sitivity, type IV). Allergic angioedema is proceeded 
through type I hypersensitivity reaction. Such an al-
lergic reaction is induced by the allergen binding to 
IgE, which is bound to the receptor, creating a signal 
for an intercellular cascade, which in turn results in 
the activation and release of mediators of inflamma-
tion. Significantly, IgE has a unique structure of its Fc 
fragment through which it binds itself to the mast cell 
and basophil receptor (FcεRI). Following this bind-
ing, the release of histamine, leukotrienes, chemot-
actic substances, platelet activating factors, proteases 
occurs, during which process degranulation of mast 
cells takes place.
The creation of cytotropic IgE antibodies and their 
binding to target cells takes about 14 days, while the 
repeated intake of allergen into the body results in 
reaction of the allergen to the antibodies bound to 
target cells, which in turn results in degranulation 
and the release of various mediators with a more or 
less apparent allergy reaction22. Some individuals are 
genetically prone to local allergy reactions (atopy) ac-
companied by large amounts of IgE. 
Type of angioedema and its relative 
proportion in the group of angioedema  Characteristics Occurrence
Hereditary angioedema (1%-2%) Autosomally dominant inherited genetic mutation affecting C1 INH protein or coagulation factor XII Rare
ACE inhibitor induced angioedema (30%) Delayed onset (days to months after the first use of ACE inhibitor) Common
Idiopathic angioedema (38%) Cause of angioedema is unknown; usually relapsing and occurring with urticaria Common
Acute allergic angioedema (30%) Allergen induced (e.g., food, drugs, radiologic contrast media, latex gloves) Common






Figure 2. Relative proportion of various types of angioe-
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Different allergens have been defined as the cause 
of atopic reactions (flower pollen, house dust, animal 
fur and feather, sometimes milk and eggs, etc.)22-25. If 
allergens become absorbed and arrive via blood into 
the skin, they can induce localized erythema, swell-
ing and pruritus (urticaria and angioedema). Reac-
tion between allergen and IgE results in aggregation 
of receptors and activation of protein-tyrosine-kinase 
sites on their inner cellular part. Thereby, a sequence 
of complex processes starts, which finally leads to 
degranulation of target cells and the release of me-
diators22-25. After IgE bridging, adenylyl-cyclase is ac-
tivated within the membrane, subsequently creating 
cAMP that engages in reactions of moving granules 
towards the cell membrane. A few minutes after its 
rise, the concentration of cAMP in cells is lowered to 
its initial level22. 
Mediators which are produced and stored in gran-
ules are thence released by the process of degranulation 
(primary mediators), as secondary mediators are being 
produced after the bridging of IgE. Their synthesis 
is carried out by calcium ions, which activate phos-
pholipase A2, an enzyme that releases arachidonic 
acid from membrane phospholipids. Metabolites of 
arachidonic acid are chemical compounds that act as 
secondary mediators: lipoxygenase activity produces 
leukotrienes, while cyclooxygenase activity produces 
prostaglandins22.
The released mediators are primarily locally effec-
tive, causing increased permeability of blood capillar-
ies, vasodilatation, smooth muscle contraction, and se-
cretion of mucous glands. This first, acute phase takes 
place within the first 15-30 minutes following allergen 
exposure. Tissue infiltration with inflammatory cells 
increases within the next 6-12 hours (eosinophils → 
neutrophils → mononuclears), leading to the late phase 
of reaction with clinical symptoms of inflammation 
(symptoms of rhinitis, asthma or angioedema)23. 
Secondary mediators include leukotrienes (also 
called slow reading substance of anaphylaxis, SRS-
A)22. The ability of attracting eosinophils is shown by 
histamine and a few chemotactic factors, for example 
eosinophil chemotactic factor of anaphylaxis (ECF-
A), which is released from mast cells and basophilic 
leukocytes at the site of allergy reaction22. A few hours 
after the onset of reaction, the late phase of reaction 
often occurs, its most important features being marked 
infiltration by eosinophils, neutrophils, basophils, 
macrophages and lymphocytes. The major treatment 
options for such reactions are antihistamines, which 
prevent most but not all allergy hypersensitivity reac-
tions, considering the role of other mediators active in 
these events. 
Clinical Findings in Angioedema
Angioedema affects more often women than men. 
Considering age, it is most common in young adults. 
Sometimes there is a short prodromal period, still the 
patient usually experiences sudden swelling of the 
skin and mucosa, accompanied by little or no itch6. 
Typical sites of edema are eyelids, lips, genitals and 
distal parts of extremities. The affected skin is usually 
pale, sometimes slightly red. Normally, there is one or 
only a few lesions. The swelling reaches its maximum 
in several hours and starts to dwindle afterwards. The 
whole process typically lasts between 8 and 72 hours6. 
Angioedema is often associated with urticaria26.
In angioedema, there is a risk of edema of the 
tongue, the larynx and the trachea, which can lead to 
airway obstruction and death, therefore tracheotomy 
is indicated. In frequent recurrences, the same site is 
usually affected as in previous cases.
Diagnosis of Angioedema 
Diagnostic criteria in angioedema are similar to 
those in urticaria6,27. For determining allergy as the 
etiology of angioedema, taking patient medical histo-
ry is important to define the potential triggering fac-
tors. Family history has to be taken in order to exclude 
any hereditary components1. Medical history is the 
key factor to diagnosis. Skin testing is most important 
(primarily prick test), and if it is not available, then in 
vitro tests can be performed, for example the radioal-
lergosorbent test (RAST). In that case, by determin-
ing the IgE specific for certain allergens, an allergy to 
potential allergens can be demonstrated via blood. In 
patients with positive family history of hereditary an-
gioedema or with an assumption for decreased levels 
of C1 INH, serum markers for complement activity 
are evaluated1.
In allergy disease diagnostics, it is important to ex-
amine family records of allergy diseases, as well as the 
patient medical history from his/her youngest age on. 
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The allergy basis for disease is often verified through 
evaluation of total IgE and the result of skin testing is 
complemented by findings of IgE specific to a certain 
allergen. The sort of testing essential to perform is 
determined by a detailed medical history and clinical 
examination of the patient. Allergy testing is mostly 
performed on the skin, whereby very small amounts 
of a standardized solution of purified allergens are ap-
plied either into the skin or on its surface, observing 
and measuring any local allergy reaction of the skin. 
Skin testing for verification of type I reaction may 
be performed by various methods, e.g., by puncture 
(prick test), application of allergen by scratching the 
skin (scratch test) and rarely by an intradermal test, 
i.e. applying the allergen into the skin using a needle. 
Prick testing is the commonest method used to iden-
tify hypersensitivity to inhalation and nutritive aller-
gens. This test is performed on the skin of the forearm 
by placing a small amount of potential allergen ex-
tract, which is then pierced by a lancet. Within 20-30 
minutes, a positive outcome will exhibit a wheal or 
swelling at the site of piercing. The size of the wheal 
may correlate with the intensity of allergic reaction. 
The test is performed for exhibiting early allergic re-
actions, such as urticaria and angioedema, drug al-
lergies, allergic rhinitis and conjunctivitis, prurigo, 
strophulus infantum, atopic dermatitis and allergic 
vasculitis.
Prick test is the most often performed testing be-
cause of its simplicity, safety and fewer false-positive 
results. Prick testing is considered to be a simple and 
harmless method6. Severe reactions in prick testing are 
extremely rare. Still, on very rare occasions systemic 
anaphylactic reaction and a life threatening condition 
may occur during the testing, therefore a physician 
with a ready to use anti-shock equipment should be 
present at the testing. A disadvantage of prick test-
ing is lower sensitivity as compared with other allergy 
tests, therefore more sensitive tests may be needed af-
ter a negative prick test, if an assumption of allergy is 
made by the physician. 
Scarification test (test by scratching) is performed 
on the volar side of the forearm previously cleansed 
with alcohol or petrol. A lancet is used to scratch a lin-
ear furrow on the surface of the skin (must not bleed), 
at a length of about 3 cm, onto which a buffer solution 
(negative control) and later on allergens, separately 
in test concentrations, are applied. The test is used 
to demonstrate hypersensitivity to preservatives, ad-
ditives, drugs and fresh nutritive allergens. Reaction 
is observed 20 minutes afterwards. A wheal with a 
transverse diameter greater than 3 mm (+) is consid-
ered as a positive reaction. 
Differential Diagnosis in Angioedema
In angioedema there are, unlike urticaria, many 
potential diagnoses that are significant for differential 
diagnosis. Firstly, assessment of hereditary angioede-
ma and cognate acquired C1 INH deficiency should 
be made. Hereditary angioedema is almost never ac-
companied by urticaria which, on the contrary, may 
be present besides the acquired form of angioedema. 
The hereditary variant has also more often intestinal 
symptoms. In all cases, the level of C1 INH should be 
measured6. Episodic angioedema with urticaria and 
eosinophilia is very rare. Having been considered part 
of the hypereosinophilic syndrome, it is nevertheless 
most likely a separate, benign disorder28. Thereby, 
urticaria and swelling frequently affect the head, the 
neck and the upper part of the torso, with a relatively 
durable angioedema, persisting even for a few days. 
Such an edema is caused by degranulation of eosino-
phils and the release of a main protein, which then 
causes degranulation of mast cells6. 
Acute allergic dermatitis, which can exhibit local-
ized edema, should also be considered on differential 
diagnosis, supposing a visible erythema, pruritus and 
often vesicles. Early manifestations of herpes zoster, 
especially on the face, can sometimes be accompa-
nied by a more intensive swelling, although there is a 
characteristic one-sided erythema, therefore making 
it possible to distinguish from angioedema. The be-
ginning of erysipelas is also marked by swelling, often 
around the lips, however, the skin is erythematous, 
the lesions are gradually progressing peripherally and 
the patient has fever with leukocytosis6. 
With the lips being affected, it could be a case of 
Melkersson-Rosenthal syndrome, yet the swelling is 
much more massive. Oral allergy syndrome is also 
possible as the most common manifestation of allergy 
to food, significantly more common in individuals 
who are also allergic to pollen. In this phenomenon, 
proteins similar to those in pollen are found in apple, 
pear, peach, nectarine, carrot, celery, sour cherry, ki-
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wifruit, tomato, banana and melon, so that, whilst 
consuming these viands, the oral cavity and the pe-
rioral region react with swelling, erythema and pru-
ritus. 
Treatment for Angioedema
The crucial factor for successful treatment is de-
tection and avoidance of triggers, early recognition of 
an attack and prompt aid offering when airways are 
affected1. Certainly, the list of medications that the 
patient is taking should be investigated, which may 
point to the usage of ACE inhibitors or angiotensin 
receptor blockers. The initial treatment for the pa-
tient in the majority of forms of angioedema is tak-
ing antihistamines which, by blocking histamine cell 
receptors, are disabling the activity of histamine and 
glucocorticoids, while epinephrine is given if there is 
fear from laryngeal edema. 
There are multiple treatment principles for allergic 
angioedema. Firstly, it is essential to identify the al-
lergen and to try to avoid it. If this is not possible, 
desensitization therapy could be carried out. Corti-
costeroids are also useful to stabilize the lysosomal 
membrane hence complicating degranulation as well 
as agents that hinder the conversion of histidine into 
histamine by inhibition of histidine decarboxylase en-
zyme22. The amount of mediators released from target 
cells can also be decreased using substances that hin-
der the entering of calcium ions into cells (cromolyn 
sodium), beta-receptor stimulants that increase the 
cell concentration of cAMP (adrenaline, isoprotere-
nol) or by giving teofilin that hinders the inactivation 
of cAMP by inhibiting phosphodiesterase22. 
Angioedema in Clinical Practice
Angioedema as sudden swelling of the skin, the 
mucosa or both, including digestive tract, is some-
times causing practical problems in determining its 
etiology29. Allergic angioedema (caused by IgE medi-
ated reaction) most often appears as a hypersensitiv-
ity reaction to various causative agents such as drugs, 
food, insect poison, and others29,30. 
Research has been done stating immunogenetic 
differences between Caucasians and people of Asian 
origin, manifesting in clinical presentation of aller-
gic diseases31-34. Furthermore, differences in dietary 
habits and socioeconomic status between the Western 
and Asian countries may create differences in allergen 
hypersensitivity30.
Kulthanan et al. conducted a study that included 
100 angioedema patients30. Results showed the an-
gioedema to manifest mostly on the periorbital skin 
and the lips, with 49% of patients having general 
symptoms. The most common cause of angioedema 
was allergic reaction to various substances. As it is af-
firmed, around half of these patients had urticaria at 
the same time. Allergic angioedema was mostly food 
induced (41.7 %), especially by seafood, followed by 
medication (39.6%). Among foods, angioedema was 
mostly caused by seafood (70%). Out of medications, 
angioedema was mostly caused by antibiotics (63.2%), 
especially amoxicillin (25%). Recurrences of angioe-
dema were frequently observed (in 39% of cases)30. 
Idiopathic recurrent angioedema is characterized 
by 3 or more episodes of angioedema occurring with 
no identifiable cause within 6 to 12 months. Patients 
with severe or recurrent episodes of angioedema as 
well as patients with C1 INH deficiency should be 
referred to a specialist in allergy-immunology1. 
Acute allergic angioedema is often accompanied 
by urticaria, which has the same etiopathogenesis29,30. 
Allergy reactions to food, drugs, environmental con-
tacts, insect stings and other substances may cause 
instantaneous IgE-mediated hypersensitivity reac-
tion. Systemic release of histamine and other media-
tors from mast cells can cause angioedema, or even a 
more comprehensive alteration, all the way to a sys-
temic anaphylactic reaction. Allergic angioedema oc-
curs more frequently in patients who also have allergic 
rhinitis, asthma and atopic dermatitis30. 
Common triggers in mast cell-mediated angioe-
dema are medications (aspirin, NSAIDs, antihyper-
tensives, narcotics and oral contraceptives), food (nuts, 
eggs, shellfish, soy, wheat, milk) and other substances 
(venom, latex)1.
Reactions to food and drugs, however, may emerge 
even without correlation to allergy. In this way, some 
medications like radiocontrast media and opiates 
can cause a non-immune degranulation of mast cells 
(pseudoallergic reactions), which do not include an 
immune mechanism. 
As in acute urticaria, medical history is crucial to 
identify the cause of angioedema. Most patients are 
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generally aware of the relation of allergens and drugs 
with the development of acute angioedema. It is most 
important to perform skin tests with occasional con-
duction of RAST of single allergens, especially in case 
of dermographism, extended skin changes, very young 
children, persisting skin changes, etc.  
Evidence for specific hypersensitivity to allergens 
is crucial for future treatment29,30. Detection of the 
responsible allergen indicates avoidance of the aller-
gen as to evade the occurrence of future allergic reac-
tions.
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Sažetak
IZRAŽENA OBILJEŽJA ALERGIJSKOG ANGIOEDEMA NA SLUZNICI USNE ŠUPLJINE
T. Duvančić, L. Lugović-Mihić, A. Brekalo, M. Šitum i A. Šinković
Angioedem označava akutni potkožni edem koji obilježava nepravilno ograničeno oticanje kože ili sluznice koje se 
javlja jednokratno ili opetovano. Edem se obično javlja u predjelu periorbite, usnica, jezika, udova i crijevne stijenke. Po-
kazalo se da je angioedem često izazvan uzimanjem inhibitora angiotenzin-konvertirajućeg enzima (ACE) ili alergijom 
na neke alergene (alergijski ili angioedem posredovan IgE-om), zatim deficijencijom C1 inhibitora (nasljedni i stečeni 
angioedem) ili je uzrok nepoznat (idiopatski angioedem). Pokazalo se da bolesnici s angioedemom često imaju i urtikariju, 
što se zapaža u oko 50% slučajeva. Najčešće se radi o alergijskoj reakciji tipa I. na neke alergene hrane ili lijekova ili na 
ubod insekata. Utvrđeno je da su najčešći uzroci alergijskog angioedema ubodi pčela i osa, reakcije na lijekove ili injekcije 
za testiranje preosjetljivosti te određena hrana (osobito jaja, školjke i orašasti plodovi). U dijagnostičkom pogledu važno je 
utvrditi potencijalni alergen, što se najčešće izvodi kožnim testovima, kao što je ubodni test i dr. Rizično kod angioedema 
je oticanje jezika, grkljana i dušnika, što može dovesti do začepljenja dišnih putova i smrti, pa je tada indicirana i traheo-
tomija. Početno liječenje bolesnika u većini oblika alergijskog angioedema je uzimanje antihistaminika i glukokortikoida, 
dok se epinefrin daje ako postoji bojazan od edema grkljana.
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